Clinical Trials Browser

INDUSTRY × infigratinib × CNS × Clear all

NCT05222165 2023-02-23

NEWEL

Phase 1/2 Withdrawn

Central Nervous System Neoplasms

NCT01975701 2019-12-04

A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

Phase 2 Completed

26 enrolled 10 charts

Glioblastoma